Clinical trial

Glyburide vs Glucovance in the Treatment of GDM

NCT02726490

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2016-07-01

PhaseEARLY_PHASE1

Study timeline

Study start (unknown)2016-07-01Date precision: month

Registry last updated2020-10-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Gestational Diabetesunresolved

Interventions

GlyburideDRUG · verified · RxNorm: glyburide

GlucovanceDRUG

Sponsors & collaborators

Texas Tech University Health Sciences Center, El Pasolead sponsor

Mapped research locations

El PasoTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02726490 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.